...
首页> 外文期刊>Chemical biology and drug design >Combined Pharmacophore and 3D-QSAR Study on A Series of Staphylococcus aureus Sortase A inhibitors
【24h】

Combined Pharmacophore and 3D-QSAR Study on A Series of Staphylococcus aureus Sortase A inhibitors

机译:药理学和3D-QSAR联合研究一系列金黄色葡萄球菌分选酶A抑制剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Methicillin resistant Staphylococcus aureus has become a major health concern and it requires new therapeutic agents. Staphylococcus aureus Sortase A enzyme contributes in adherence of bacteria with the cell wall of host cell; consequently, inhibition of S. aureus Sortase A by small molecules could be employed as potential antibacterial agents against methicillin resistant S. aureus. Current study focused on the identification of 3D pharmacophoric features within a series of rhodanine, pyridazinone, and pyrazolethione analogs as S. aureus Sortase A inhibitors. Pharmacophore model was constructed employing representative molecules using Genetic Algorithm with Linear Assignment of Hypermolecular Alignment of Database. The identified pharmacophoric points were then utilized to create alignment hypothesis for three-dimensional quantitative structure-activity relationships. Outcome of comparative molecular field analysis and comparative molecular similarity indices analysis experiments were in good agreement (comparative molecular field analysis: q~2 = 0.562 and r~2 = 0.995, comparative molecular similarity indices analysis: q~2 = 0.549 and r~2 = 0.978) and capable of explaining the variance in biological activities coherently with respect to the structural features of compounds. The results were also found in concurrence with the outcome of pharmacophoric features.
机译:耐甲氧西林的金黄色葡萄球菌已成为主要的健康问题,需要新的治疗药物。金黄色葡萄球菌分选酶A酶有助于细菌与宿主细胞的细胞壁粘附。因此,小分子对金黄色葡萄球菌分选酶A的抑制作用可以用作对耐甲氧西林的金黄色葡萄球菌的潜在抗菌剂。目前的研究集中在鉴定作为金黄色葡萄球菌分选酶A抑制剂的一系列罗丹宁,哒嗪酮和吡唑硫酮类似物中的3D药效学特征。使用遗传算法对具有代表性的分子进行建模,并以数据库的超分子比对为线性分配来建立药效团模型。然后,将已识别的药效学点用于建立三维定量结构-活性关系的比对假设。比较分子场分析结果与比较分子相似性指标分析实验的结果吻合良好(比较分子场分析:q〜2 = 0.562和r〜2 = 0.995,比较分子相似性指数分析:q〜2 = 0.549和r〜2 = 0.978),并且能够解释生物活性相对于化合物结构特征的变化。还发现结果与药效学特征的结果一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号